Covid-19 Impact on Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, Global Research Reports 2020-2021

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Development
  • 1.4.3 API production
  • 1.4.4 Formulation
• 1.5 Market by Application
  • 1.5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Application: 2020 VS 2026
  • 1.5.2 Pharmaceutical
  • 1.5.3 Biopharmaceutical
• 1.6 Coronavirus Disease 2019 (Covid-19): Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Growth Trends by Regions
  • 2.2.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Historic Market Share by Regions (2015-2020)
  • 2.2.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Contract Research Organization (CRO) and CDMO for Pharmaceutical Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Contract Research Organization (CRO) and CDMO for Pharmaceutical Players by Market Size
  • 3.1.1 Global Top Contract Research Organization (CRO) and CDMO for Pharmaceutical Players by Revenue (2015-2020)
  • 3.1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Ratio
  • 3.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue in 2019
• 3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players Head office and Area Served
• 3.4 Key Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Solution and Service
• 3.5 Date of Enter into Contract Research Organization (CRO) and CDMO for Pharmaceutical Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Historic Market Size by Type (2015-2020)
• 4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)
• 5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 6.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in North America (2019-2020)
• 6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 6.4 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 7.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in Europe (2019-2020)
• 7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 7.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 8.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in China (2019-2020)
• 8.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 8.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 9.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in Japan (2019-2020)
• 9.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 9.4 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 10.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 10.4 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 11.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in India (2019-2020)
• 11.3 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 11.4 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2015-2020)
• 12.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2015-2020)
• 12.4 Central & South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Recipharm
  • 13.1.1 Recipharm Company Details
  • 13.1.2 Recipharm Business Overview and Its Total Revenue
  • 13.1.3 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.1.4 Recipharm Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020))
  • 13.1.5 Recipharm Recent Development and Reaction to COVID-19
• 13.2 AMRI3
  • 13.2.1 AMRI3 Company Details
  • 13.2.2 AMRI3 Business Overview and Its Total Revenue
  • 13.2.3 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.2.4 AMRI3 Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.2.5 AMRI3 Recent Development and Reaction to COVID-19
• 13.3 Patheon
  • 13.3.1 Patheon Company Details
  • 13.3.2 Patheon Business Overview and Its Total Revenue
  • 13.3.3 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.3.4 Patheon Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.3.5 Patheon Recent Development and Reaction to COVID-19
• 13.4 Aenova
  • 13.4.1 Aenova Company Details
  • 13.4.2 Aenova Business Overview and Its Total Revenue
  • 13.4.3 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.4.4 Aenova Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.4.5 Aenova Recent Development and Reaction to COVID-19
• 13.5 Catalent
  • 13.5.1 Catalent Company Details
  • 13.5.2 Catalent Business Overview and Its Total Revenue
  • 13.5.3 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.5.4 Catalent Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.5.5 Catalent Recent Development and Reaction to COVID-19
• 13.6 Amatsigroup
  • 13.6.1 Amatsigroup Company Details
  • 13.6.2 Amatsigroup Business Overview and Its Total Revenue
  • 13.6.3 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.6.4 Amatsigroup Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.6.5 Amatsigroup Recent Development and Reaction to COVID-19
• 13.7 WuXi PharmaTech
  • 13.7.1 WuXi PharmaTech Company Details
  • 13.7.2 WuXi PharmaTech Business Overview and Its Total Revenue
  • 13.7.3 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.7.4 WuXi PharmaTech Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.7.5 WuXi PharmaTech Recent Development and Reaction to COVID-19
• 13.8 Strides Shasun
  • 13.8.1 Strides Shasun Company Details
  • 13.8.2 Strides Shasun Business Overview and Its Total Revenue
  • 13.8.3 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.8.4 Strides Shasun Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.8.5 Strides Shasun Recent Development and Reaction to COVID-19
• 13.9 Piramal
  • 13.9.1 Piramal Company Details
  • 13.9.2 Piramal Business Overview and Its Total Revenue
  • 13.9.3 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.9.4 Piramal Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.9.5 Piramal Recent Development and Reaction to COVID-19
• 13.10 Siegfried
  • 13.10.1 Siegfried Company Details
  • 13.10.2 Siegfried Business Overview and Its Total Revenue
  • 13.10.3 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
  • 13.10.4 Siegfried Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2015-2020)
  • 13.10.5 Siegfried Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer